20 . March , 2019 - Wednesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Oxycodone Acetaminophen

Big Image
Generic Name: oxycodone hydrochloride and acetaminophen
Dosage Form: Tablets

CII

Rx only

Oxycodone Acetaminophen Description

Oxycodone hydrochloride and acetaminophen is supplied in tablet form for oral administration.

Each oxycodone and acetaminophen tablet, USP 5 mg*/325 mg tablet contains:

            Oxycodone Hydrochloride, USP 5 mg (*equivalent to 4.4815 mg Oxycodone)
            Acetaminophen, USP 325 mg

Each oxycodone and acetaminophen tablet, USP 7.5 mg*/325 mg tablet contains:

            Oxycodone Hydrochloride, USP 7.5 mg (*equivalent to 6.7228 mg Oxycodone)
            Acetaminophen, USP 325 mg

Each oxycodone and acetaminophen tablet, USP 7.5 mg*/500 mg tablet contains:

            Oxycodone Hydrochloride, USP 7.5 mg (*equivalent to 6.7228 mg Oxycodone)
            Acetaminophen, USP 500 mg

Each oxycodone and acetaminophen tablet, USP 10 mg*/325 mg tablet contains:

            Oxycodone Hydrochloride, USP 10 mg (*equivalent to 8.9637 mg Oxycodone)
            Acetaminophen, USP 325 mg

All strengths of oxycodone and acetaminophen tablets, USP also contain the following inactive ingredients: crospovidone NF, microcrystalline cellulose NF, povidone USP, pregelatinized starch NF, silicon dioxide NF and stearic acid NF.

Acetaminophen, 4'-hydroxyacetanilide, is a non-opiate, non-salicylate analgesic and antipyretic which occurs as a white, odorless, crystalline powder, possessing a slightly bitter taste. It may be represented by the following structural formula:

Oxycodone, 14-hydroxydihydrocodeinone, is a semisynthetic opioid analgesic which occurs as a white, odorless, crystalline powder having a saline, bitter taste. It is derived from the opium alkaloid thebaine. Oxycodone hydrochloride may be represented by the following structural formula:

Oxycodone Acetaminophen - Clinical Pharmacology

The principal ingredient, oxycodone, is a semisynthetic opioid analgesic with multiple actions qualitatively similar to those of morphine; the most prominent involves the central nervous system and organs composed of smooth muscle. The principal actions of therapeutic value of the oxycodone in oxycodone and acetaminophen tablets are analgesia and sedation.

Oxycodone is similar to codeine and methadone in that it retains at least one-half of its analgesic activity when administered orally.

Acetaminophen is a non-opiate, non-salicylate analgesic and antipyretic.

Indications and Usage for Oxycodone Acetaminophen

Oxycodone and acetaminophen tablets, USP are indicated for the relief of moderate to moderately severe pain.

Contraindications

This product should not be administered to patients who are hypersensitive to oxycodone, acetaminophen, or any other components of this product.

Warnings

Drug Dependence

Oxycodone can produce drug dependence of the morphine type and, therefore, has the potential for being abused. Psychic dependence, physical dependence and tolerance may develop upon repeated administration of oxycodone and acetaminophen tablets, and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral opioid-containing medications. Like other opioid-containing medications, oxycodone and acetaminophen tablets are subject to the Federal Controlled Substances Act (Schedule II).

Precautions

General

Head Injury and Increased Intracranial Pressure: The respiratory depressant effects of opioids and their capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury, other intracranial lesions or a pre-existing increase in intracranial pressure. Furthermore, opioids produce adverse reactions which may obscure the clinical course of patients with head injuries.

Acute Abdominal Conditions: The administration of oxycodone and acetaminophen tablets or other opioids may obscure the diagnosis or clinical course in patients with acute abdominal conditions.

Special Risk Patients: Oxycodone and acetaminophen tablets should be given with caution to certain patients such as the elderly or debilitated, and those with severe impairment of hepatic or renal function, hypothyroidism, Addison's disease, and prostatic hypertrophy or urethral stricture.

Information for Patients

Oxycodone may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. The patient using oxycodone and acetaminophen tablets should be cautioned accordingly.

Drug Interactions

Patients receiving other opioid analgesics, general anesthetics, phenothiazines, other tranquilizers, sedative-hypnotics or other CNS depressants (including alcohol) concomitantly with oxycodone and acetaminophen tablets may exhibit an additive CNS depression. When such combined therapy is contemplated, the dose of one or both agents should be reduced.

The concurrent use of anticholinergics with opioids may produce paralytic ileus.

Usage in Pregnancy

Teratogenic Effects; Pregnancy Category C: Animal reproductive studies have not been conducted with oxycodone and acetaminophen. It is also not known whether oxycodone and acetaminophen tablets can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Oxycodone and acetaminophen tablets should not be given to a pregnant woman unless in the judgment of the physician, the potential benefits outweigh the possible hazards.

Nonteratogenic Effects: Use of opioids during pregnancy may produce physical dependence in the neonate.

Labor and Delivery: As with all opioids, administration of oxycodone and acetaminophen tablets to the mother shortly before delivery may result in some degree of respiratory depression in the newborn and the mother, especially if higher doses are used.

Nursing Mothers

It is not known whether the active components of this product are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when oxycodone and acetaminophen tablets are administered to a nursing woman.

Pediatric Use

Safety and effectiveness in pediatric patients have not been established.

Adverse Reactions

The most frequently observed adverse reactions include light-headedness, dizziness, sedation, nausea and vomiting. These effects seem to be more prominent in ambulatory than in nonambulatory patients, and some of these adverse reactions may be alleviated if the patient lies down.

Other adverse reactions include euphoria, dysphoria, constipation, skin rash and pruritus. At higher doses, oxycodone has most of the disadvantages of morphine including respiratory depression.

Drug Abuse and Dependence

Oxycodone and acetaminophen tablets are a Schedule II controlled substance.

Oxycodone can produce drug dependence and has the potential for being abused (see WARNINGS).

Overdosage

Acetaminophen

Signs and Symptoms: In acute acetaminophen overdosage, dose-dependent, potentially fatal hepatic necrosis is the most serious adverse effect. Renal tubular necrosis, hypoglycemic coma and thrombocytopenia may also occur.

In adults, hepatic toxicity has rarely been reported with acute overdoses of less than 10 grams and fatalities with less than 15 grams. Importantly, young children seem to be more resistant than adults to the hepatotoxic effect of an acetaminophen overdose. Despite this, the measures outlined below should be initiated in any adult or child suspected of having ingested an acetaminophen overdose.

Early symptoms following a potentially hepatotoxic overdose may include: nausea, vomiting, diaphoresis and general malaise. Clinical and laboratory evidence of hepatic toxicity may not be apparent until 48 to 72 hours post-ingestion.

Treatment: The stomach should be emptied promptly by lavage or by induction of emesis with syrup of ipecac. Patient's estimates of the quantity of a drug ingested are notoriously unreliable. Therefore, if an acetaminophen overdose is suspected, a serum acetaminophen assay should be obtained as early as possible, but no sooner than four hours following ingestion. Liver function studies should be obtained initially and repeated at 24-hour intervals.

The antidote, N-acetylcysteine, should be administered as early as possible, preferably within 16 hours of the overdose ingestion for optimal results, but in any case, within 24 hours. Following recovery, there are no residual, structural, or functional hepatic abnormalities.

Oxycodone

Signs and Symptoms: Serious overdosage with oxycodone is characterized by respiratory depression (a decrease in respiratory rate and/or tidal volume, Cheyne-Stokes respiration, cyanosis), extreme somnolence progressing to stupor or coma, skeletal muscle flaccidity, cold and clammy skin, and sometimes bradycardia and hypotension. In severe overdosage, apnea, circulatory collapse, cardiac arrest and death may occur.

Treatment: Primary attention should be given to the reestablishment of adequate respiratory exchange through provision of a patent airway and the institution of assisted or controlled ventilation. The opioid antagonist naloxone hydrochloride is a specific antidote against respiratory depression which may result from overdosage or unusual sensitivity to opioids, including oxycodone. Therefore, an appropriate dose of naloxone hydrochloride (usual initial adult dose 0.4 mg to 2 mg) should be administered preferably by the intravenous route, and simultaneously with efforts at respiratory resuscitation (see package insert). Since the duration of action of oxycodone may exceed that of the antagonist, the patient should be kept under continued surveillance and repeated doses of the antagonist should be administered as needed to maintain adequate respiration.

An antagonist should not be administered in the absence of clinically significant respiratory or cardiovascular depression. Oxygen, intravenous fluids, vasopressors and other supportive measures should be employed as indicated.

Gastric emptying may be useful in removing unabsorbed drug.

Oxycodone Acetaminophen Dosage and Administration

Dosage should be adjusted according to the severity of the pain and the response of the patient. It may occasionally be necessary to exceed the usual dosage recommended below in cases of more severe pain or in those patients who have become tolerant to the analgesic effect of opioids. Oxycodone and acetaminophen tablets are given orally. The usual adult dosage is one tablet every 6 hours as needed for pain. The total daily dose of acetaminophen should not exceed 4 grams (maximal daily dose of oxycodone and acetaminophen tablets 7.5 mg/325 mg and oxycodone and acetaminophen tablets 7.5 mg/500 mg is 8 tablets, and for oxycodone and acetaminophen tablets 10 mg/325 mg is 6 tablets).

How is Oxycodone Acetaminophen Supplied

Each oxycodone and acetaminophen tablet, USP 5 mg/325 mg contains oxycodone hydrochloride 5 mg (equivalent to 4.4815 mg oxycodone) and acetaminophen 325 mg. It is available as a round, white scored tablet debossed with a 512 identification number.

            Bottles of 100.......................NDC No. 0406-0512-01
            Bottles of 500.......................NDC No. 0406-0512-05
            Unit Dose (10x10)...............NDC No. 0406-0512-62

Each oxycodone and acetaminophen tablet, USP 7.5 mg/325 mg contains oxycodone hydrochloride 7.5 mg (equivalent to 6.7228 mg oxycodone) and acetaminophen 325 mg. It is available as a white to off-white caplet shaped tablet debossed with “M522” on one side and “7.5/325” on the other side.

            Bottles of 100.......................NDC No. 0406-0522-01
            Unit Dose (10x10)...............NDC No. 0406-0522-62

Each oxycodone and acetaminophen tablet, USP 7.5 mg/500 mg contains oxycodone hydrochloride 7.5 mg (equivalent to 6.7228 mg oxycodone) and acetaminophen 500 mg. It is available as a white to off-white oval shaped tablet debossed with “M582” on one side and the other side is plain.

            Bottles of 100.......................NDC No. 0406-0582-01
            Unit Dose (10x10)...............NDC No. 0406-0582-62

Each oxycodone and acetaminophen tablet, USP 10 mg/325 mg contains oxycodone hydrochloride 10 mg (equivalent to 8.9637 mg oxycodone) and acetaminophen 325 mg. It is available as a white to off-white caplet shaped tablet debossed with “M523” on one side and “10/325” on the other side.

            Bottles of 100.......................NDC No. 0406-0523-01
            Unit Dose (10x10).......…....NDC No. 0406-0523-62

Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature].

Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).

DEA Order Form Required.

Tyco

Healthcare

Mallinckrodt

Mallinckrodt Inc.

St. Louis, Missouri 63134, U.S.A.

Rev. 080206


Oxycodone Hydrochloride and Acetaminophen (Oxycodone hydrochloride and Acetaminophen)
PRODUCT INFO
Product Code 0406-0512 Dosage Form TABLET
Route Of Administration ORAL DEA Schedule CII
INGREDIENTS
Name (Active Moiety) Type Strength
Oxycodone Hydrochloride (Oxycodone) Active 5 MILLIGRAM  In 1 TABLET
Acetaminophen (Acetaminophen) Active 325 MILLIGRAM  In 1 TABLET
crospovidone Inactive  
microcrystalline cellulose Inactive  
povidone Inactive  
pregelatinized starch Inactive  
silicon dioxide Inactive  
stearic acid Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color WHITE (WHITE) Score 2
Shape ROUND (ROUND) Symbol false
Imprint Code 512 Coating false
Size 12mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0406-0512-01 100 TABLET In 1 BOTTLE None
2 0406-0512-05 500 TABLET In 1 BOTTLE None
3 0406-0512-62 100 TABLET In 1 BLISTER PACK None

Oxycodone Hydrochloride and Acetaminophen (Oxycodone hydrochloride and Acetaminophen)
PRODUCT INFO
Product Code 0406-0522 Dosage Form TABLET
Route Of Administration ORAL DEA Schedule CII
INGREDIENTS
Name (Active Moiety) Type Strength
Oxycodone Hydrochloride (Oxycodone) Active 7.5 MILLIGRAM  In 1 TABLET
Acetaminophen (Acetaminophen) Active 325 MILLIGRAM  In 1 TABLET
crospovidone Inactive  
microcrystalline cellulose Inactive  
povidone Inactive  
pregelatinized starch Inactive  
silicon dioxide Inactive  
stearic acid Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color WHITE (off-white) Score 1
Shape OVAL (OVAL) Symbol false
Imprint Code M522;7.5/325 Coating false
Size 15mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0406-0522-01 100 TABLET In 1 BOTTLE None
2 0406-0522-62 100 TABLET In 1 BLISTER PACK None

Oxycodone Hydrochloride and Acetaminophen (Oxycodone hydrochloride and Acetaminophen)
PRODUCT INFO
Product Code 0406-0582 Dosage Form TABLET
Route Of Administration ORAL DEA Schedule CII
INGREDIENTS
Name (Active Moiety) Type Strength
Oxycodone Hydrochloride (Oxycodone) Active 7.5 MILLIGRAM  In 1 TABLET
Acetaminophen (Acetaminophen) Active 500 MILLIGRAM  In 1 TABLET
crospovidone Inactive  
microcrystalline cellulose Inactive  
povidone Inactive  
pregelatinized starch Inactive  
silicon dioxide Inactive  
stearic acid Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color WHITE (off-white) Score 1
Shape OVAL (OVAL) Symbol false
Imprint Code M582 Coating false
Size 18mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0406-0582-01 100 TABLET In 1 BOTTLE None
2 0406-0582-62 100 TABLET In 1 BLISTER PACK None

Oxycodone Hydrochloride and Acetaminophen (Oxycodone hydrochloride and Acetaminophen)
PRODUCT INFO
Product Code 0406-0523 Dosage Form TABLET
Route Of Administration ORAL DEA Schedule CII
INGREDIENTS
Name (Active Moiety) Type Strength
Oxycodone Hydrochloride (Oxycodone) Active 10 MILLIGRAM  In 1 TABLET
Acetaminophen (Acetaminophen) Active 325 MILLIGRAM  In 1 TABLET
crospovidone Inactive  
microcrystalline cellulose Inactive  
povidone Inactive  
pregelatinized starch Inactive  
silicon dioxide Inactive  
stearic acid Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color WHITE (off-white) Score 1
Shape OVAL (OVAL) Symbol false
Imprint Code M523;10/325 Coating false
Size 16mm
PACKAGING
# NDC Package Description Multilevel Packaging
1 0406-0523-01 100 TABLET In 1 BOTTLE None
2 0406-0523-62 100 TABLET In 1 BLISTER PACK None

Revised: 03/2007

Recent Drug Updates at DrugIndexOnline:





Apo-Meprobamate Apo-Meprobamate
Some commonly used brand names are: In the U.S.— Equanil Meprospan 200 Meprospan 400 Miltown-200 Miltown-400 Miltown-600 Probate Trancot In Canada— Apo-Meprobamate Equanil Meprospan-400 Miltown Generic name product may be available in the U.S. Category Antianxiety agent D more...

Chap Stick Sunblock Petroleum Jelly Plus Topical Chap Stick Sunblock Petroleum Jelly Plus Topical
Some commonly used brand names are: In the U.S.— A-Fil 33 Aquaderm Sunscreen Moisturizer 49 Aquaray Sunscreen 42 Bain de Soleil All Day For Kids 38 Bain de Soleil All Day Sunfilter 39 Bain de Soleil Mega Tan 34 Bain de Soleil Orange Gelee 41 Bain de Soleil Sand Buster 41 Bain de Soleil SP more...

Cromolyn Sodium (Disodium Cromoglycate) Cromolyn Sodium (Disodium Cromoglycate)
( Disodium Cromoglycate ) Pronouncation: (KROE-moe-lin SO-dee-um) Class: Mast cell stabilizer Trade Names: Crolom - Solution, ophthalmic 4% Trade Names: Cromolyn sodium - Solution, inhalation 20 mg per 2 mL - Solution, ophthalmic 4% Trade Names: Gastrocrom - Concentrate, oral 100 mg per 5 mL Trade more...

Elavil Elavil
Generic name: Amitriptyline hydrochloride Brand names: Elavil Why is Elavil prescribed? Elavil is prescribed for the relief of symptoms of mental depression. It is a member of the group of drugs called tricyclic antidepressants. Some doctors also prescribe Elavil to treat bulimia (an eating diso more...

Monistat 5 Tampon Vaginal Monistat 5 Tampon Vaginal
Some commonly used brand names are: In the U.S.— FemCare 2 Femizol-M 4 Femstat 3 1 Gyne-Lotrimin 2 Gyne-Lotrimin Combination Pack 2 Gyne-Lotrimin3 2 Gyne-Lotrimin3 Combination Pack 2 Miconazole-7 4 Monistat 1 6 Monistat 1 Combination Pack 4 Monistat 3 4 Monistat 3 Combination Pack 4 Monis more...

Penetrex Penetrex
Generic Name: enoxacin (ee NOX ah sin) Brand Names: Penetrex What is Penetrex (enoxacin)? Enoxacin is an antibiotic in a class of drugs called fluoroquinolones. It fights bacteria in the body. Enoxacin is used to treat various bacterial infections, such as gonorrhea and urinary tract in more...

Pimecrolimus Pimecrolimus
Generic Name: Pimecrolimus (pim-e-KROE-li-mus) Brand Name: ElidelThe long-term safety of Pimecrolimus has not been determined. Because rare cases of cancer (eg, lymphoma, skin cancer) have been reported, continuous long-term use should be avoided and the application of Pimecrolimus should be l more...

Propecia Propecia
Generic Name: finasteride (fih NAH steh ride) Brand Names: Propecia, Proscar What is finasteride? Finasteride prevents the conversion of testosterone to dihydrotestosterone (DHT) in the body. DHT is involved in the development of benign prostatic hyperplasia (BPH) and hair loss. Finaster more...